Eagle Asset Management’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-239
| Closed | -$17K | – | 541 |
|
|
2022
Q3 | $17K | Hold |
239
| – | – | ﹤0.01% | 542 |
|
|
2022
Q2 | $37K | Hold |
239
| – | – | ﹤0.01% | 556 |
|
|
2022
Q1 | $147K | Buy |
+239
| New | +$147K | ﹤0.01% | 564 |
|
|
2021
Q4 | – | Sell |
-436
| Closed | -$1.22M | – | 607 |
|
|
2021
Q3 | $1.22M | Buy |
436
+40
| +10% | +$112K | 0.01% | 508 |
|
|
2021
Q2 | $2.14M | Buy |
396
+240
| +154% | +$1.3M | 0.01% | 478 |
|
|
2021
Q1 | $175K | Buy |
156
+39
| +33% | +$43.8K | ﹤0.01% | 582 |
|
|
2020
Q4 | $157K | Buy |
+117
| New | +$157K | ﹤0.01% | 519 |
|
|
2018
Q4 | – | Sell |
-120
| Closed | -$320K | – | 607 |
|
|
2018
Q3 | $320K | Hold |
120
| – | – | ﹤0.01% | 593 |
|
|
2018
Q2 | $319K | Hold |
120
| – | – | ﹤0.01% | 598 |
|
|
2018
Q1 | $489K | Hold |
120
| – | – | ﹤0.01% | 586 |
|
|
2017
Q4 | $302K | Sell |
120
-30
| -20% | -$75.5K | ﹤0.01% | 608 |
|
|
2017
Q3 | $552K | Hold |
150
| – | – | ﹤0.01% | 570 |
|
|
2017
Q2 | $613K | Hold |
150
| – | – | ﹤0.01% | 585 |
|
|
2017
Q1 | $775K | Hold |
150
| – | – | ﹤0.01% | 598 |
|
|
2016
Q4 | $766K | Hold |
150
| – | – | 0.01% | 595 |
|
|
2016
Q3 | $640K | Hold |
150
| – | – | ﹤0.01% | 598 |
|
|
2016
Q2 | $775K | Hold |
150
| – | – | 0.01% | 601 |
|
|
2016
Q1 | $672K | Sell |
150
-4
| -3% | -$17.9K | ﹤0.01% | 593 |
|
|
2015
Q4 | $737K | Hold |
154
| – | – | ﹤0.01% | 597 |
|
|
2015
Q3 | $1.54M | Hold |
154
| – | – | 0.01% | 581 |
|
|
2015
Q2 | $1.07M | Buy |
154
+13
| +9% | +$90.4K | 0.01% | 610 |
|
|
2015
Q1 | $1.76M | Hold |
141
| – | – | 0.01% | 566 |
|
|
2014
Q4 | $1.86M | Buy |
141
+2
| +1% | +$26.4K | 0.01% | 555 |
|
|
2014
Q3 | $1.38M | Buy |
139
+1
| +0.7% | +$9.93K | 0.01% | 605 |
|
|
2014
Q2 | $2.19M | Buy |
138
+21
| +18% | +$334K | 0.01% | 587 |
|
|
2014
Q1 | $2.27M | Buy |
117
+2
| +2% | +$38.9K | 0.01% | 603 |
|
|
2013
Q4 | $2.17M | Buy |
115
+20
| +21% | +$378K | 0.01% | 580 |
|
|
2013
Q3 | $1.03M | Hold |
95
| – | – | 0.01% | 668 |
|
|
2013
Q2 | $1.17M | Buy |
+95
| New | +$1.17M | 0.01% | 648 |
|